Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Muller

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
BMJ Open|August 10, 2022
Comparative-effectiveness research of COVID-19 treatment: a rapid scoping reviewBa Pham, Patricia Rios, Amruta Radhakrishnan, et al.
Vaccine|September 3, 2024
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccinesBrenda L Coleman, Iris Gutmanis, Susan J Bondy, et al.
Scientific Reports|October 30, 2020
Dissemination of Verona Integron-encoded Metallo-β-lactamase among clinical and environmental Enterobacteriaceae isolates in Ontario, CanadaPhilipp Kohler, Nathalie Tijet, Hyunjin C Kim, et al.
Emerging Infectious Diseases|August 21, 2018
Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada<sup>1</sup>Philipp P Kohler, Roberto G Melano, Samir N Patel, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Journal of Virology|June 1, 2007
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndromeMark J Cameron, Longsi Ran, Luoling Xu, et al.
Archives of Internal Medicine|June 27, 2007
One-year outcomes and health care utilization in survivors of severe acute respiratory syndromeCatherine M Tansey, Marie Louie, Mark Loeb, et al.
Plos One|September 11, 2012
The impact of infection on population health: results of the Ontario burden of infectious diseases studyJeffrey C Kwong, Sujitha Ratnasingham, Michael A Campitelli, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
JAMA Network Open|February 10, 2026
Invasive Group A Streptococcal Disease in Persons Experiencing Postpandemic Homelessness in CanadaCaroline Kassee, Halima Dabaja-Younis, Lucie Richard, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BMJ Open|August 10, 2022
Comparative-effectiveness research of COVID-19 treatment: a rapid scoping reviewBa Pham, Patricia Rios, Amruta Radhakrishnan, et al.
Vaccine|September 3, 2024
Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccinesBrenda L Coleman, Iris Gutmanis, Susan J Bondy, et al.
Scientific Reports|October 30, 2020
Dissemination of Verona Integron-encoded Metallo-β-lactamase among clinical and environmental Enterobacteriaceae isolates in Ontario, CanadaPhilipp Kohler, Nathalie Tijet, Hyunjin C Kim, et al.
Emerging Infectious Diseases|August 21, 2018
Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada<sup>1</sup>Philipp P Kohler, Roberto G Melano, Samir N Patel, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Journal of Virology|June 1, 2007
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndromeMark J Cameron, Longsi Ran, Luoling Xu, et al.
Archives of Internal Medicine|June 27, 2007
One-year outcomes and health care utilization in survivors of severe acute respiratory syndromeCatherine M Tansey, Marie Louie, Mark Loeb, et al.
Plos One|September 11, 2012
The impact of infection on population health: results of the Ontario burden of infectious diseases studyJeffrey C Kwong, Sujitha Ratnasingham, Michael A Campitelli, et al.
Vaccine|March 5, 2026
Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 eraAltynay Shigayeva, Brenda L Coleman, Alyssa R Golden, et al.
JAMA Network Open|February 10, 2026
Invasive Group A Streptococcal Disease in Persons Experiencing Postpandemic Homelessness in CanadaCaroline Kassee, Halima Dabaja-Younis, Lucie Richard, et al.
Pageof 9